LAKE OSWEGO, Ore., Jan. 30, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet medical needs to advance cancer care, today announced that Mark J. Ahn, Ph.D., President and Chief Executive Officer, will provide a presentation entitled, “Advancing Personalized Medicine with Peptide-Based Cancer Vaccines” at The Immunotherapeutics Partnering and Dealmaking Conference. The presentation will take place on Tuesday, January 31, 2012 at 11:35 am PST at the Paradise Point Resort and Spa in San Diego, CA.
